Tomatoes, lycopene, and prostate cancer

Proceedings of the Society for Experimental Biology and Medicine

Volumn 218, Issue 2, 1998, Pages 129-139

  Giovannucci, Edward ^a   Clinton, Steven K ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYCOPENE;

ANTINEOPLASTIC ACTIVITY; CANCER RISK; CONFERENCE PAPER; DIET; ENVIRONMENTAL FACTOR; FOOD INTAKE; FOOD PREFERENCE; GENETIC SUSCEPTIBILITY; HORMONAL REGULATION; PATHOGENESIS; PROSTATE CANCER; RISK ASSESSMENT; TOMATO;

LYCOPERSICON ESCULENTUM;

EID: 0031782426     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-218-44277     Document Type: Conference Paper

References (95)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer Statistics, 1997. CA Cancer J Clin 47:5-27, 1997.
2. Staszewski W, Haenszel W. Cancer mortality among the Polish-born in the United States. J Natl Cancer Inst 35:291-297, 1965.
3. Haenszel W, Kurihara M. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 40:43-68, 1968.
4. Haas GP, Sakr WA. Epidemiology of prostate cancer. CA Cancer J Clin 47:273-287, 1997.
5. Bostwick DG. High grade prostatic intraepithelial neoplasia: The most likely precursor of prostate cancer. Cancer 75:1823-1836, 1995.
6. McNeal JE. Morphogenesis of prostatic carcinoma. Cancer 18:1659-1666, 1965.
7. Qian J, Bostwick DG. The extent and zonal location of prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia: Relationship with carcinoma in radical prostatectomy specimens. Pathol Res Pract 191:860-867, 1995.
8. Shiraishi T, Watanabe M, Matsuura H, Kusano I, Yatani R, Stemmerman GN. The frequency of latent prostate carcinoma in young males: The Japanese experience. In Vivo 8:445-447, 1994.
9. Sakr WA, Haas GP, Cassin BF, Pontes FE, Grissman JD. The frequency of carcinoma and intraepithelial neoplasia of prostates in young male patients. J Urol 150:379-385, 1993.
10. Sakr WA, Haas GP, Grignon DJ, Heilbrun LK, Cassin BJ, Pontes JE, Crissman JD. High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: An autopsy study of 249 cases. In Vivo. 8:439-444, 1994.
11. Guileyardo JM, Johnson WD, Welsh RA, Akazaki K, Correa P. Prevalence of latent prostate carcinoma in two U.S. populations. J Natl Cancer Inst 65:311-316, 1980.
12. Sakr WA, Haas GP, Cassin BF, Pontes FE, Crissman JD. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol 150:379-385, 1993.
13. Aus G. Prostate cancer: Mortality and morbidity after noncurative treatment with aspects on diagnosis and treatment. Scand J Urol Nephrol (Suppl) 167:1-41, 1994.
14. Gronberg H, Damber L, Damber JE. Studies of genetic factors in prostate cancer in a twin population. J Urol 152:1484-1489, 1994.
15. Kantoff PW, Febbo PG, Giovannucci E, Krithivas K, Dahl DM, Chang G, Hennekens CH, Brown M, Stampfer MJ. A polymorphism of the 5α-reductase gene and its association with prostate cancer: A case-control analysis. Cancer Epidemiol Biomarkers Prev 6:189-192, 1997.
16. Giovannucci E, Stampfer MJ, Krithivas K, Brown M, Brufsky A, Talcott J, Hennekens CH, Kantoff PW. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci USA 94:3320-3323, 1997.
17. Bosland MD. The etiopathogenesis of prostatic cancer with special reference to environmental factors. Adv Cancer Res 51:1-106, 1988.
18. Blair A, Zahm SH. Cancer among farmers. Occupational Med 6:335-354, 1991.
19. Van der Gulden JW, Kolk JJ, Verbeek AL. Prostate cancer and work environment. J Occup Med 34:402-409, 1992.
20. Nomura A, Kolonel L. Prostate cancer: A current perspective. Epidemiol Rev 13:200-226, 1991.
21. Matzkin H, Soloway MS. Cigarette smoking: A review of possible associations with benign prostatic hyperplasia and prostate cancer. Prostate 22:277-290, 1993.
22. Hsing AW, Mclaughlin JK, Schulman LM, Bjelke E, Gridley G, Wacholder S, Co Chien HT, Blot WJ. Diet, tobacco use, and fatal prostate cancer: Results from the Lutheran Brotherhood cohort study. Cancer Res 50:6836-6840, 1990.
23. Hsing AW, Mclaughlin JK, Hrubec Z, Blot WJ, Fraumeni JF. Tobacco use and prostate cancer: 26-year follow-up of US veterans. Am J Epidemiol 133:437-441, 1991.
24. Coughlin SS, Neaton JD, Sengupta A. Cigarette smoking as a predictor of death from prostate cancer in 348,874 men screened for the Multiple Risk Factor Intervention Trial. Am J Epidemiol 143:1002-1006, 1996.
25. Daniell HW. A worse prognosis for smokers with prostate cancer. J Urol 154:153-157, 1995.
26. Hussain F, Aziz H, Macchia R, Avitable M, Rotman M. High grade adenocarcinoma of prostate in smokers of ethnic minority groups and Caribbean island immigrants. Int J Radiat Oncol Biol Phys 24:451-461, 1992.
27. Giovannucci E, Ascherio A, Rimm EB, Colditz G, Stampfer MJ, Willett WC. A prospective cohort study of vasectomy and prostate cancer in U.S. men. JAMA 269:873-877, 1993.
28. Ghanadian R, Puah CM, O'Donoghue EP. Serum testosterone and dihydrotestosterone in carcinoma of the prostate. Br J Cancer 39:696-699, 1979.
29. Ahluwalia B, Jackson MA, Jones GW, Williams AO, Rao MS, Rajguru S. Blood hormone profiles in prostate cancer patients in high-risk and low-risk populations. Cancer 48:2267-2273, 1981.
30. Ross RK, Coetzee GA, Reichardt J, Skinner E, Henderson BE. Does the racial-ethnic variation in prostate cancer risk have a hormonal basis? Cancer 75:1778-1782, 1995.
31. Ross RK, Bernstein L, Judd H, Hanisch R, Pike MC, Henderson BE. Serum testosterone levels in young black and white men. J Natl Cancer Inst 76:45-48, 1986.
32. Ellis L, Nyborg H. Racial/ethnic variations in male testosterone levels: A probable contributor to group differences in health. Steroids 57:72-75, 1992.
33. Henderson BE, Bernstein L, Ross RK, Depue RH, Judd HL. The early in utero oestrogen and testosterone environment of blacks and whites: Potential effects on male offspring. Br J Cancer 57:216-218, 1988.
34. Field AE, Colditz GA, Willett WC, Longcope C, McKinlay JB. The relation of smoking, age, relative weight, and dietary intake to serum adrenal steroids, sex hormones, and sex hormone-binding globulin in middle-aged men. J Clinical Endocrinol Metab 79:1310-1316, 1994.
35. Gann PH, Hennekens CH, Ma J, Longcope C, Stampfer MJ. A prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst 88:1118-1126, 1996.
36. Fund WCR. Food, Nutrition and the Prevention of Cancer: A Global Perspective. Washington, D.C.: American Institute for Cancer Research, p670, 1997.
37. Clinton SK, Giovannucci E. Nutrition in the etiology and prevention of cancer. In: Holland JF, Frei E, Bast BC, Kufe DW, Morton DL, Weichselbaum RR, Eds. Cancer Medicine. Philadelphia: Williams and Wilkins, pp465-494, 1997.
38. Clinton SK, Giovannucci E. Diet, Nutrition, and Prostate Cancer. Annual Reviews of Nutrition 18:413-440, 1998.
39. Pienta KJ, Espar PS. Risk factors for prostate cancer. Ann Intern Med 118:793-803, 1993.
40. American Cancer Society. Guidelines of diet, nutrition, and cancer prevention: Reducing the risk of cancer with healthy food choices and physical activity, CA. Cancer J Clin 46:325-341, 1996.
41. Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 15:617-631, 1975.
42. Carroll KK, Hohr HT. Dietary fat in relation to tumorigenesis. Prog Biochem Pharmacol 10:308-353, 1975.
43. Whittemore AS, Kolonel LN, Wu AH, John EM, Gallagher RP, Howe GR, Burch D, Hankin J, Dreon DM, West DW, Teh C, Paffenbarger RS Jr. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and asians in the United States and Canada. J Natl Cancer Inst 87:652-661, 1995.
44. Rose DP, Cohen LA. Effects of dietary menhaden oil and retinyl acetate on the growth of DU 145 human prostatic adenocarcinoma cells transplanted into athymic nude mice. Carcinogenesis 9:603-605, 1988.
45. Rose DP, Connolly JM. Effects of fatty acids and eicosanoid synthesis inhibitors on the growth of two human prostate cancer cell lines. The Prostate 18:243-254, 1991.
46. Clinton SK, Palmer SS, Spriggs CE, Visek WJ. The growth of Dunning transplantable prostate adenocarcinomas in rats fed diets varying in fat content. J Nutr 118:1577-1585, 1988.
47. Wang Y, Corr JG, Thaler HT, Tao Y, Fair WR, Heston WDW. Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J Natl Cancer Inst 87:1456-1462, 1995.
48. Hursting SD, Thornquist M, Henderson MM. Types of dietary fat and the incidence of cancer at 5 sites. Prev Med 19:242-253, 1990.
49. Giovannucci E, Rimm EB, Colditz GA, Stampfer MJ, Ascherio A, Chute CC, Willett WC. A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst 85:1571-1579, 1993.
50. West DW, Slattery ML, Robinson LM, French TK, Mahoney AW. Adult dietary intake and prostate cancer risk in Utah: A case-control study with special emphasis on aggressive tumors. Cancer Causes Control 2:85-94, 1991.
51. Clinton SK, Mulloy AL, Li SP, Mangian HJ, Visek WJ. Dietary fat and protein intake differ in modulation of prostate tumor growth, prolactin secretion and metabolism, and prostate gland prolactin binding capacity in rats. J Nutr 127:225-237, 1997.
52. Talamini R, Lavecchia C, Decarli A, Negri E, Francechi S. Nutrition, social factors, and prostatic cancer in a Northern Italian population. Br J Cancer 53:817-821, 1986.
53. Talamini R, Franceschi S, La Vecchia C, Serraino D, Barra S, Negri E. Diet and prostatic cancer: A case-control study in northern Italy. Nutr Cancer 18:277-286, 1992.
54. Mettlin C, Selenskas S, Natarajan N, Huben R. Beta-carotene and animal fats and their relationship to prostate cancer risk: A case-control study. Cancer 64:605-612, 1989.
55. Snowdon DA, Phillips RL, Choi W. Diet, obesity, and risk of fatal prostate cancer. Am J Epidemiol 120:244-250, 1984.
56. Mills PK, Beeson WL, Phillips RL, Fraser GE. Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer 64:598-604, 1989.
57. Severson RK, Nomura AMY, Grove JS, Stemmermann GN. A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 49:1857-1860, 1989.
58. Le Marchand L, Kolonel LN, Wilkins LR, Myers BC, Hirohata T. Animal fat consumption and prostate cancer: A prospective study in Hawaii. Epidemiology 5:276-282, 1994.
59. Gann PH, Hennekens CH, Sacks FM, Grodstein F, Giovannucci E, Stampfer MJ. A prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst 86:281-286, 1994.
60. The alpha-tocopherol beta-carotene cancer prevention study group. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N Eng J Med 330:1029-1035, 1994.
61. Bern HA. Alkaline phosphatase activity in epithelial metaplasia. Cancer Res 12:86-91, 1952.
62. Lasnitzki I. The influence of a hyperviaminosis on the effect of 20-methylcholanthrene on mouse prostate glands grown in vitro. Brit J Cancer 9:434-441, 1955.
63. Boyd D, Beynon L, Chisholm GD, Habib FK. Characterization of the retinol and retinoic acid binding proteins in the human prostate. Cancer Res 44:5532-5537, 1984.
64. Gesell MS, Brandes MJ, Arnold EA, Isaacs JT, Ueda H, Millan JC, Brandes D. Retinoic acid binding protein in normal and neoplastic rat prostate. Prostate 3:131-138, 1982.
65. Jutley JK, Kelleher J, Whelan P, Mikel J. Cytosolic retinoic acid-binding protein in human prostatic dysplasia and neoplasia. Prostate 11:127-132, 1987.
66. Chopra DP, Wilkoff LJ. Effect of retinoids and estrogens on testosterone-induced hyperplasia of mouse prostate explants in organ culture. Proc Soc Exp Biol Med 162:229-234, 1979.
67. Jutley JK, Reaney S, Kelleher J, Whelan P. Interactions of retinoic acid and androgens in human prostatic tissue. Prostate 16:299-304, 1990.
68. Pienta KJ, Nguyen NM, Lehr JE. Treatment of prostate cancer in the rat with the synthetic retinoid fenretinide. Cancer Res 53:224-226, 1993.
69. Pollard M, Luckert PH, Sporn MB. Prevention of primary prostate cancer in Lobund-Wistar rats by N-(4-hydroxyphenyl)retinamide. Cancer Res. 51:3610-3611, 1991.
70. + myc-induced carcinomas in the mouse prostate reconstitution model system. Cancer Res 53:4461-4465, 1993.
71. Mayne ST, Graham S, Zheng T. Dietary retinol: Prevention or promotion of carcinogenesis in humans? Cancer Causes Control 2:443-450, 1991.
72. Clark LC, Combs GF, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher JL, Park HK, Sanders BB, Smith CL, Taylor JR. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276:1957-1963, 1996.
73. Corder EH, Guess HA, Hulka BS, Friedman GD, Sadler M, Vollmer RT, Lobaugh B, Drezner MK, Vogelman JH, Orentreich N. Vitamin D and prostate cancer: A prediagnostic study with stored sera. Cancer Epidemiol Biomarkers Prev 2:457-472, 1993.
74. Gann PH, Ma J, Hennekens CH, Hollis BW, Haddad JG, Stampfer MJ. Circulating vitamin D metabolites in relation to subsequent development of prostate cancer. Cancer Epidemiol Biomarkers and Prev 5:212-216, 1996.
75. 3 on primary cultures of human prostatic cells. Cancer Res 54:805-810, 1994.
76. 3 receptors and actions in human prostate cancer cell lines. Endocrinology 132:1952-1960, 1993.
77. 3 in seven human prostatic carcinoma cells lines. Clin Cancer Res 1:997-1003, 1995.
78. 3 in androgen-dependent LNCaP cells. Biochem Biophys Res Commun 223:141-146, 1996.
79. Esquenet M, Swinnen JV, Heyns W, Vehoeven G. Control of LNCaP proliferation and differentiation: Actions and interactions of androgens, 1-alpha,25-dihydroxycholecalciferol, all-trans retinoic acid, 9-cis retinoic acid, and phenylacetate. Prostate 28:182-194, 1996.
80. Lucia MS, Anzano MA, Slayter MV, Anver MB, Green DM, Schrader MW, Logsdon DL, Driver CL, Brown CC, Peer CW, Roberts AB, Sporn MB. Chemopreventive activity of tamoxifen, N-(4-hydroxyphenyl)retinamide, and the vitamin D analogue RO-5531 for androgen-promoted carcinomas of the rat seminal vesicle and prostate. Cancer Res 55:5621-5627, 1995.
81. 3 and prostate cancer cell proliferation in vivo. Urology 46:365-369, 1995.
82. Mangels AR, Holden JM, Beecher GR, Forman M, Lanza E. Carotenoid content of fruits and vegetables: An evaluation of analytic data. J Am Diet Assoc 93:284-296, 1993.
83. Clinton SK, Emenhiser C, Schwartz SJ, Bostwick DG, Williams AW, Moore BJ, Erdman JW Jr. cis-trans Lycopene isomers, carotenoids, and retinol in the human prostate. Cancer Epidemiol Biomarkers Prev 5:823-833, 1996.
84. Council NR. Diet and Health. Washington, D.C.: National Academy Press, 1989.
85. Connolly JM, Rose DP. Effects of fatty acids on invasion through reconstituted basement membrane (Matrigel) by a human breast cancer cell line. Cancer Lett 75:137-142, 1993.
86. Clinton SK. Diet, anthropometry and breast cancer: Integration of experimental and epidemiologic approaches. J Nutr 127:916s-920s, 1997.
87. Giovannucci EL, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Intake of carotenoids and retinol in relationship to risk of prostate cancer. J Natl Cancer Inst 87:1767-1776, 1995.
88. Stahl W, Sies H. Uptake of lycopene and its geometrical isomers is greater from heat-processed than from unprocessed tomato juice in humans. J Nutr 122:2161-2166, 1992.
89. Schuman LM, Mandel JS, Radke A, Seal U, Halberg F. Some selected features of the epidemiology of prostatic cancer: Minneapolis-St. Paul, case-control study, 1976-1979. In: Magnus K, Ed. Trends in Cancer Incidence: Causes and Implications, Washington, D.C.: Hemisphere Publishing Corp., pp345-354, 1982.
90. Le Marchand L, Hankin JH, Kolonel LN, Wilkins LR. Vegetable and fruit consumption in relation to prostate cancer risk in Hawaii: A reevaluation of the effect of dietary beta-carotene. Am J Epidemiol 133:215-219, 1991.
91. Hsing AW, Comstock GW, Abbey H, Polk BR. Serologic precursors of cancer: Retinol, carotenoids, and tocopherol and risk of prostate cancer. J Natl Cancer Inst 82:941-946, 1990.
92. Nomura AMY, Stemmermann GN, Lee J, Craft NE. Serum micronutrients and prostate cancer in Japanese Americans in Hawaii. Cancer Epidemiol Biomarkers Prev 6:487-492, 1997.
93. Mayne ST. Beta-carotene, carotenoids, and disease prevention in humans. FASEB J 10:690-701, 1996.
94. Block G, Patterson B, Subar A. Fruit, vegetables, and cancer prevention: A review of the epidemiological evidence. Nutr Cancer 18:1-29, 1992.
95. Stenmetz KA, Potter JD. A review of vegetables, fruit, and cancer. I. Epidemiology. Cancer Causes Control 2:427-442, 1991.